ESLA Q1 2026 Earnings EPS Misses Estimates by Wide Margin as ClinicalStage Biotech Continues RD Spending NTLA Q1 2026 Earnings Narrowerthanexpected loss signals continued progress in gene editing pipeline AFYA Q1 2026 Earnings EPS Misses Estimates Stock Edges Lower Amid Margin Pressure First Bancorp FBNC Q1 2026 Earnings EPS Slightly Beats Estimates Amid Stable Operations Amicus Therapeutics Q4 2025 Earnings EPS Misses Expectations by a Wide Margin QVCGP Q3 2025 Earnings Significant Loss Per Common Share Reported Preferred Stock Unchanged